Latest Annexin Pharmaceuticals News & Updates

See the latest news and media coverage for Annexin Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Annexin Pharmaceuticals

Clinical-stage biotechnology company developing Annexin A5 therapeutics

annexinpharma.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Public company
Number of employees
5–10

Last updated

Latest news about Annexin Pharmaceuticals

In short: Annexin Pharmaceuticals advanced its Phase 2a NEXUS study for ANXV in eye diseases while securing multiple rounds of financing via rights issues.

Company announcements

Annexin Pharmaceuticals

Annexin Pharmaceuticals advances ANXV in ophthalmology

Expands into diabetic retinopathy with Prof. Paulo Eduardo Stanga's team at The Retina Clinic London.

Unlock all announcements with a

Media coverage

Barron's

Annexin Pharmaceuticals AB

Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale...

FinanzNachrichten

Annexin Pharmaceuticals AB: Annexin secures financing through bridge loan facility and plans a rights issue of approximately SEK 20 million during the summer of 2026

Annexin Pharmaceuticals AB (publ) today announces that the company has secured bridge financing of approximately SEK 4 million and intends to carry out a rights...

Unlock all articles with a

Never miss news about Annexin Pharmaceuticals

Track Annexin Pharmaceuticals and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Annexin Pharmaceuticals competitors & trending companies

Browse news for competitors to Annexin Pharmaceuticals and other trending companies.